HK7091A - Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives - Google Patents

Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives Download PDF

Info

Publication number
HK7091A
HK7091A HK70/91A HK7091A HK7091A HK 7091 A HK7091 A HK 7091A HK 70/91 A HK70/91 A HK 70/91A HK 7091 A HK7091 A HK 7091A HK 7091 A HK7091 A HK 7091A
Authority
HK
Hong Kong
Prior art keywords
substituted
alkoxy
aliphatic
aliphatic hydrocarbyl
group
Prior art date
Application number
HK70/91A
Other languages
German (de)
English (en)
French (fr)
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Michael Arthur Stockham
Original Assignee
National Research Development Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corporation filed Critical National Research Development Corporation
Publication of HK7091A publication Critical patent/HK7091A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK70/91A 1983-09-23 1991-01-24 Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives HK7091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838325496A GB8325496D0 (en) 1983-09-23 1983-09-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK7091A true HK7091A (en) 1991-02-01

Family

ID=10549201

Family Applications (1)

Application Number Title Priority Date Filing Date
HK70/91A HK7091A (en) 1983-09-23 1991-01-24 Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives

Country Status (11)

Country Link
US (1) US4587240A (enExample)
EP (1) EP0138420B1 (enExample)
JP (2) JPS6094966A (enExample)
CY (1) CY1574A (enExample)
DE (1) DE3480599D1 (enExample)
DK (1) DK161703C (enExample)
GB (2) GB8325496D0 (enExample)
GR (1) GR80444B (enExample)
HK (1) HK7091A (enExample)
SG (1) SG93290G (enExample)
ZA (1) ZA847409B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
US5667933A (en) * 1996-02-26 1997-09-16 Polaroid Corporation Image-recording element
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US7135196B2 (en) * 2000-09-19 2006-11-14 Vitra Pharmaceuticals Limited Iron compositions
MXPA04007832A (es) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
HRP20060073B1 (hr) 2003-07-23 2014-03-14 Bayer Healthcare Llc Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja
NZ600874A (en) 2007-03-28 2013-01-25 Apotex Technologies Inc Fluorinated derivatives of deferiprone
MX2010011701A (es) 2008-04-25 2010-12-06 Apotex Technologies Inc Formulacion liquida para deferiprona con gusto agradable al paladar.
PT2448922E (pt) 2009-07-03 2014-12-02 Apotex Technologies Inc Derivados fluorados de 3-hidroxipiridina-4-onas
JP5648120B2 (ja) 2010-03-23 2015-01-07 ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ 鉄欠乏症および鉄欠乏性貧血の治療および予防用の鉄（ｉｉｉ）錯体化合物
JP5923161B2 (ja) * 2011-03-29 2016-05-24 ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ 鉄欠乏症状および鉄欠乏性貧血の治療および予防のための鉄（ｉｉｉ）錯体化合物
WO2012163938A1 (de) 2011-05-31 2012-12-06 Vifor (International) Ag Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
KR20140143832A (ko) * 2012-04-05 2014-12-17 비포르 (인터내셔날) 아게 철 결핍 증상 및 철 결핍 빈혈의 치료 및 예방을 위한 Fe(III)-피라진 착화합물
CA2891572A1 (en) 2012-12-21 2014-06-26 Vifor (International) Ag Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748142A (en) * 1956-05-29 - process of production
GB778871A (en) * 1955-02-14 1957-07-10 Sadolin & Holmblad As Pyridinediol oxides and acetates thereof and their preparation
GB790584A (en) * 1955-02-15 1958-02-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
GB791719A (en) * 1955-02-15 1958-03-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
FR3691M (fr) * 1963-05-06 1965-11-15 Olin Mathieson Nouvelle composition pharmaceutique utile en tant que fongicide.
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US3968118A (en) * 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
US3705943A (en) * 1969-07-18 1972-12-12 Olin Corp Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides
EG10850A (en) * 1972-03-25 1976-06-30 Hoechst Ag Process for the preparation of 1-hydroxy-pyridones
DE2705562A1 (de) * 1977-02-10 1978-08-17 Basf Ag Verfahren zur herstellung von pyridonen
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
JPS5832812A (ja) * 1981-08-21 1983-02-25 Lion Corp 毛髪化粧料
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
DE3278014D1 (en) * 1982-10-01 1988-02-25 Merck & Co Inc Aralkylaminoethanol heterocyclic compounds
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents

Also Published As

Publication number Publication date
EP0138420B1 (en) 1989-11-29
GB2146990B (en) 1987-05-20
JPH0566385B2 (enExample) 1993-09-21
EP0138420A2 (en) 1985-04-24
CY1574A (en) 1991-12-20
GR80444B (en) 1985-01-23
DK161703B (da) 1991-08-05
DK161703C (da) 1992-01-20
DK453584D0 (da) 1984-09-21
GB8325496D0 (en) 1983-10-26
JPS6094966A (ja) 1985-05-28
DK453584A (da) 1985-03-24
GB2146990A (en) 1985-05-01
JPH05246992A (ja) 1993-09-24
GB8423800D0 (en) 1984-10-24
JPH0811729B2 (ja) 1996-02-07
ZA847409B (en) 1986-05-28
EP0138420A3 (en) 1987-05-20
DE3480599D1 (de) 1990-01-04
US4587240A (en) 1986-05-06
SG93290G (en) 1991-01-18

Similar Documents

Publication Publication Date Title
EP0138420B1 (en) Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives
US4666927A (en) Pharmaceutical compositions of hydroxypyridones
US4912118A (en) Pharmaceutical compositions
US4585780A (en) Pharmaceutical compositions
EP0145228B1 (en) Pharmaceutical compositions
EP0093498B1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
EP0120670B1 (en) Iron iii complexes of hydroxypyridones, and their pharmaceutical compositions
EP0159917B1 (en) Pharmaceutical composition containing a hydroxypyrone-iron complex
USRE34313E (en) Pharmaceutical compositions
EP0094149B1 (en) Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
EP0159194A2 (en) Iron 3-hydroxypyrone or 3-hydroxypyridone complexes and pharmaceutical compositions containing them
GB2118176A (en) Pharmaceutical compositions
GB2117766A (en) Pharmaceutical compositions
JP3348849B2 (ja) ３−ヒドロキシ−４−ピロンのガリウム錯体の医薬組成物
EP0305646B1 (en) 3-Hydroxypyrid-4-ones and pharmaceutical compositions
USRE37534E1 (en) Pharmaceutical compositions
CA1338496C (en) Pharmaceutically active iron complexes of 3-hydroxy-4-pyrones

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules